Pharmaceutical Research Overview
Diamicron MR 30 SERVIER is a modified-release pharmaceutical formulation containing gliclazide, a second-generation sulfonylurea compound. Researchers at Stroid UK Shop can examine this preparation for in-vitro studies investigating glucose homeostasis mechanisms and pancreatic beta-cell physiology. The modified-release technology enables sustained compound release profiles suitable for extended laboratory protocols.
Laboratory Research Applications
Scientists investigate Diamicron MR 30 in cellular models studying insulin secretion pathways, glucose-stimulated insulin release, and beta-cell preservation mechanisms. Research applications include examining sulfonylurea receptor interactions, ATP-sensitive potassium channel modulation, and glucose metabolism in pancreatic islet cultures. Laboratory protocols often compare this preparation with other compounds available in our miscellaneous research compounds category. Researchers frequently cross-reference findings with metabolic studies using SARMs for comprehensive metabolic pathway analysis, while some protocols incorporate peptides to examine synergistic metabolic effects in controlled laboratory environments.
Technical Specifications
| Parameter | Value |
|---|---|
| Active compound | Gliclazide |
| Formulation | Modified-release tablet |
| Strength | 30mg |
| Manufacturer | SERVIER |
| CAS Number | Verify with supplier |
| Molecular formula | Verify with supplier |
| Storage conditions | Room temperature, dry environment |
Research Compliance Statement
Diamicron MR 30 SERVIER is supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical preparation is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure appropriate laboratory safety protocols, proper waste disposal procedures, and compliance with institutional research guidelines when handling this compound in controlled laboratory environments.
